Last updated: May 29, 2026

Application No. 18/015,709

THERAPEUTIC HYDROGEL FOR THE DELIVERY OF CAR-T CELLS

Non-Final OA

Filed

Jan 11, 2023

Priority

Jul 23, 2020 — provisional 63/055,738 +1 more

Examiner

BELYAVSKYI, MICHAIL A

Art Unit

1644

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

North Carolina State University

OA Round

1 (Non-Final)

This examiner grants 64% of cases after interview

— +27.5% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 1100 resolved cases, 2023–2026

Examiner Intelligence

BELYAVSKYI, MICHAIL A View full profile →

Grants 64% of resolved cases

Career Allowance Rate

702 granted / 1100 resolved

+3.8% vs TC avg

Strong +28% interview lift

Without

With

+27.5%

Interview Lift

resolved cases with interview

Typical timeline

3y 1m

Avg Prosecution

58 currently pending

Career history

1174

Total Applications

across all art units

Statute-Specific Performance

§101

2.8%

-37.2% vs TC avg

§103

34.2%

-5.8% vs TC avg

§102

11.2%

-28.8% vs TC avg

§112

12.5%

-27.5% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1100 resolved cases

Prosecution Timeline

Jan 11, 2023

Application Filed

Sep 09, 2025

Non-Final Rejection mailed

May 12, 2026

Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

17/817,273

Patent 12636318

PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY

3y 9m to grant Granted May 26, 2026

17/936,811

Patent 12637659

EXPANSION OF NON-HAEMATOPOIETIC TISSUE-RESIDENT GAMMA DELTA T CELLS AND USES OF THESE CELLS

3y 8m to grant Granted May 26, 2026

18/246,083

Patent 12636378

TARGETED ANTIGEN DELIVERY SYSTEM AND USES THEREOF

3y 2m to grant Granted May 26, 2026

17/817,239

Patent 12622927

PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY

3y 9m to grant Granted May 12, 2026

17/047,516

Patent 12612602

PRODUCTION OF A BIOENGINEERED LUNG

5y 6m to grant Granted Apr 28, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

64%

Grant Probability

91%

With Interview (+27.5%)

3y 1m (~0m remaining)

Median Time to Grant

Low

PTA Risk

Based on 1100 resolved cases by this examiner. Grant probability derived from career allowance rate.